Italy Platelet Rich Plasma (prp) Market Size & Outlook
Italy platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
Italy platelet rich plasma (prp) market highlights
- The Italy platelet rich plasma (prp) market generated a revenue of USD 25.9 million in 2023 and is expected to reach USD 68.0 million by 2030.
- The Italy market is expected to grow at a CAGR of 14.8% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 25.9 million |
| Market revenue in 2030 | USD 68.0 million |
| Growth rate | 14.8% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Italy accounted for 4.0% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 123.0 million by 2030.
Pure prp was the largest segment with a revenue share of 51.74% in 2023. Horizon Databook has segmented the Italy platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
The origins of PRP can be traced back to Italy in 1987, when clinicians introduced it for autologous transfusion in cardiac surgery patients. Over time, orthopedic surgeons adapted PRP to enhance bone graft adherence and prevent tissue dehydration.
PRP gained popularity in musculoskeletal medicine due to the abundant growth factors in platelets, which can support the healing process. As clinicians recognized its potential, commercial devices for generating PRP proliferated, enabling widespread use of this therapy for pain management and tissue repair.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
Italy Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
